Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa's Second COVID-19 Therapeutic Development Program
- Written by ACN Newswire - Press Releases
Read more //?#
.
The 95 Per Cent Failure Rate Is Not An AI Problem
Most Australian SMEs I speak with are already having a go at AI. Some are running formal pilots, others have a team member quietly experimenting o...
New AR tech helping to solve field service skills crisis
AI-enabled augmented reality (AR) smart glasses are emerging as a new practical solution to fill a shortage of field service technicians maintaini...
For Midsize Companies, Global Payroll Systems Matter More to Business-Security Than You Think
When a midsize company expands across borders, its payroll operation becomes exponentially more complex. These organisations typically face a new ...
GEO and the AI search shift reshaping Australian and New Zealand business visibility
For years, one of the biggest digital marketing questions for businesses was ‘how do we get onto page one of Google?’ That question still matters, ...
Why self-service is reshaping fleet management for modern businesses
Fleet management today is constrained by fragmented systems and heavy administrative demands. A lot of the work still relies on booking vehicles and...
Fraud Prevention and security crucial as identity crime hits record highs in Australia
In a radically transformed risk landscape where the scale and speed of financial fraud have reached unprecedented levels, Australian businesses ar...